NRX Pharmaceuticals, Inc. Common Stock NRXP
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-13T02:14:31.814Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T00:51:32.203518201Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-13T02:14:31.339490+00:00
NRX Pharmaceuticals, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | 2.44 | 183.3% | 14.8% | |||
| 50Δ | 2.35 | 206.9% | 14.0% | |||
| 55Δ | 2.27 | 230.5% | 13.3% | |||
| 60Δ | 2.18 | 254.1% | 12.5% | |||
| 65Δ | 2.09 | 277.7% | 11.7% | |||
| 70Δ | 2.01 | 301.3% | 11.0% | |||
| 75Δ | 1.86 | 314.7% | 9.1% | |||
| 80Δ | 1.70 | 327.1% | 7.0% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 2.44
- IV
- 183.3%
- B/E move
- 14.8%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 2.35
- IV
- 206.9%
- B/E move
- 14.0%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 2.27
- IV
- 230.5%
- B/E move
- 13.3%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 2.18
- IV
- 254.1%
- B/E move
- 12.5%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 2.09
- IV
- 277.7%
- B/E move
- 11.7%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 2.01
- IV
- 301.3%
- B/E move
- 11.0%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 1.86
- IV
- 314.7%
- B/E move
- 9.1%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 1.70
- IV
- 327.1%
- B/E move
- 7.0%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 162.85% | |
| 157.26% | |
| 170.99% | |
| 180.25% | |
| 172.08% | |
| 171.99% | |
| 161.85% |
Biotechnology
NRXS
NeurAxis, Inc. is a neuromodulation therapy device company in the United States. The company is headquartered in Versailles, Indiana.
More →NTLA
Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies. The company is headquartered in Cambridge, Massachusetts.
More →NUVB
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, is focused on developing therapeutic candidates for oncology. The company is headquartered in New York, New York.
More →NVAX
Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs.…
More →NVCT
Nuvectis Pharma, Inc., a biopharmaceutical company, is focused on the development of targeted small molecule therapies for the treatment of cancer. The company is headquartered in…
More →OABI
Description unavailable
More →